MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,497,593 | -92.3% | 34,380 | -93.6% | 0.00% | -90.0% |
| Q2 2023 | $19,340,714 | +875045.4% | 535,309 | +800.7% | 0.01% | +900.0% |
| Q1 2023 | $2,210 | -69.5% | 59,434 | -62.8% | 0.00% | -75.0% |
| Q4 2022 | $7,236 | -99.1% | 159,700 | +1324.4% | 0.00% | – |
| Q3 2022 | $783,000 | -94.9% | 11,212 | -95.1% | 0.00% | -100.0% |
| Q2 2022 | $15,470,000 | +56.3% | 230,440 | +91.4% | 0.01% | +100.0% |
| Q1 2022 | $9,897,000 | -13.4% | 120,372 | +54.5% | 0.01% | -16.7% |
| Q4 2021 | $11,431,000 | -46.4% | 77,928 | -35.3% | 0.01% | -50.0% |
| Q3 2021 | $21,307,000 | -73.2% | 120,441 | -75.5% | 0.01% | -75.5% |
| Q2 2021 | $79,511,000 | +250.5% | 492,237 | +271.7% | 0.05% | +206.2% |
| Q1 2021 | $22,687,000 | +129.8% | 132,443 | +194.6% | 0.02% | +100.0% |
| Q4 2020 | $9,873,000 | +118.7% | 44,952 | +65.3% | 0.01% | +33.3% |
| Q3 2020 | $4,514,000 | +43.7% | 27,188 | -33.5% | 0.01% | -14.3% |
| Q1 2020 | $3,141,000 | -23.2% | 40,863 | +28.7% | 0.01% | +40.0% |
| Q4 2019 | $4,091,000 | -82.3% | 31,742 | -89.3% | 0.01% | -86.1% |
| Q3 2019 | $23,099,000 | +40.9% | 296,509 | +86.3% | 0.04% | +44.0% |
| Q2 2019 | $16,395,000 | +4.0% | 159,178 | -26.0% | 0.02% | +8.7% |
| Q1 2019 | $15,760,000 | +134.7% | 215,000 | +50.8% | 0.02% | +187.5% |
| Q3 2018 | $6,716,000 | +1379.3% | 142,599 | +1450.0% | 0.01% | +700.0% |
| Q2 2018 | $454,000 | -96.4% | 9,200 | -97.7% | 0.00% | -94.1% |
| Q1 2018 | $12,493,000 | +139.6% | 406,924 | -8.7% | 0.02% | +112.5% |
| Q3 2017 | $5,215,000 | +555.2% | 445,709 | +104.5% | 0.01% | +700.0% |
| Q2 2017 | $796,000 | +30.1% | 217,990 | +85.3% | 0.00% | 0.0% |
| Q1 2017 | $612,000 | -20.1% | 117,664 | -27.1% | 0.00% | -50.0% |
| Q4 2016 | $766,000 | +52.0% | 161,305 | +111.4% | 0.00% | +100.0% |
| Q3 2016 | $504,000 | -68.3% | 76,301 | -73.8% | 0.00% | -75.0% |
| Q2 2016 | $1,589,000 | -21.6% | 291,098 | +207.5% | 0.00% | -20.0% |
| Q1 2016 | $2,026,000 | +163.8% | 94,676 | +289.5% | 0.01% | +150.0% |
| Q4 2015 | $768,000 | +20.8% | 24,308 | +31.6% | 0.00% | +100.0% |
| Q3 2015 | $636,000 | – | 18,472 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |